UNRESECTABLE/METASTATIC GASTRIC CANCER

Clinical trials for UNRESECTABLE/METASTATIC GASTRIC CANCER explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE/METASTATIC GASTRIC CANCER trials appear

Sign up with your email to follow new studies for UNRESECTABLE/METASTATIC GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for stomach cancer: drug cocktail targets tough cases

Disease control Not yet recruiting

This study tests a combination of the immunotherapy drug sintilimab and a chemotherapy regimen called FOLFIRI as a second-line treatment for people with advanced HER2-negative stomach cancer that has progressed after initial therapy. The goal is to see if this approach can delay …

Matched conditions: UNRESECTABLE/METASTATIC GASTRIC CANCER

Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control

Last updated Jun 22, 2026 12:07 UTC

UNRESECTABLE/METASTATIC GASTRIC CANCER

Get alerted when new UNRESECTABLE/METASTATIC GASTRIC CANCER trials appear

New hope for stomach cancer: drug cocktail targets tough cases